DPIIT recognised startup Government of India
Startup India
Chimera Biotech Private Limited
Chimera Biotech Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹47.12 Lakh
▼ 71% YoY
Net profit · FY 2025
₹70,990
Net margin 1.5%
EBITDA · FY 2025
₹13.9 Lakh
EBITDA margin 29.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.95 Cr
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Brands
1
Associated brands
About Chimera Biotech Private Limited
Data last updated:
Chimera Biotech Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 07 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2019PTC349632.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.95 Cr. It was formerly known as Chimera Textile Solutions Private Limited. It is led by directors Vikash Chandra Mishra and Naveen Vashisht.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No. 199 2nd Floor Dsiidc Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.12 Lakh, a decline of 71% compared to the previous year. For the same year it recorded a net profit of ₹70,990 (net margin 1.5%) and EBITDA of ₹13.9 Lakh (EBITDA margin 29.5%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 43% over five years.
The company is associated with 1 brand: Chimera Biotech. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Chimera Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0006954). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304DL2019PTC349632
Registration Number 349632
Incorporation Date 07 May 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0006954
Recognitions & Rankings of Chimera Biotech
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0006954
Contact details
Chimera Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShed No. 199 2nd Floor Dsiidc Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Chimera Biotech Private Limited, buy the company report.
Comprehensive company report
Chimera Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Chimera Biotech operates one associated brand: Chimera Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Ligand-binding assays are provided for pharmacokinetics, pharmacodynamics, immunogenicity, and biomarkers. | chimera-biotech.com |
Business activity
The main business activity of Chimera Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Chimera Biotech Private Limited, buy the company report.
Financials of Chimera Biotech Private Limited
FY 2025 filings availableChimera Biotech Private Limited reported revenue of ₹47.12 Lakh (down 71% YoY) for FY 2025.
Revenue · FY 2025
₹47.12 Lakh ▼ 71%
Net profit · FY 2025
₹70,990 margin 1.5%
EBITDA · FY 2025
₹13.9 Lakh margin 29.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 71%
3 years · compounded
▼ 37%
5 years · compounded
▲ 43%
EBITDA CAGR growth
1 year
▲ 486%
3 years · compounded
▲ 1%
5 years · compounded
▲ 60%
Revenue fell 71% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 43%. EBITDA rose 486% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70,990 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.5% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chimera Biotech Private Limited, buy the company report.
Board of directors of Chimera Biotech Private Limited
Chimera Biotech has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikash Chandra Mishra | Director | 07 May 2019 | 7 Years 5 Months | Current |
| Naveen Vashisht | Director | 07 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Chimera Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Disposafe Healthcare Private Limited | ₹48.11 Lakh (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Fastsense Innovations Private Limited | ₹47.15 Lakh (FY 2025) | 226.0% | Pune, Maharashtra, India | |||
| Chimera Biotech Private Limitedthis company | ₹47.12 Lakh (FY 2025) | ₹70,990 | 1.5% | -71.0% | New Delhi, Delhi, India | |
| Heglems Pharmaceuticals Private Limited | ₹46.59 Lakh (FY 2024) | 212.0% | Delhi, India |
To see the full peer comparison of Chimera Biotech Private Limited, buy the company report.
Auditor
Chimera Biotech Private Limited is audited by KAUL KAPIL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAUL KAPIL & CO | FY 2023 | 011243N |
Shareholding
The shareholding of Chimera Biotech Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Chimera Biotech Private Limited, buy the company report.
Legal cases
Chimera Biotech Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Court case (MCD CHL) | Filed against the company by an individual | Pending |
To see the full case history of Chimera Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chimera Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Chimera Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Chimera Biotech Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Naveen Vashisht was appointed as Director on 07 May 2019.
AGM
Chimera Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chimera Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Naveen Vashisht was appointed as Director.
Appointed
Vikash Chandra Mishra was appointed as Director.
Incorporation
07 May 2019
Chimera Biotech Private Limited was registered on 07 May 2019 with Roc Delhi & aged 7 years 5 months as per MCA records.
Frequently asked questions
Chimera Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 07 May 2019 (7+ years old) and is registered under CIN U24304DL2019PTC349632.
Chimera Biotech has 2 current directors:
- Vikash Chandra Mishra - Director
- Naveen Vashisht - Director
The latest financial statements of Chimera Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Chimera Biotech is U24304DL2019PTC349632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chimera Biotech has 1 court case on record: 1 filed against it. 1 is pending.
Chimera Biotech was incorporated on 07 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Chimera Biotech by revenue are Disposafe Healthcare Private Limited, Fastsense Innovations Private Limited, Heglems Pharmaceuticals Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Naveen Vashisht was appointed as Director on 07 May 2019. Vikash Chandra Mishra was appointed as Director on 07 May 2019.
Yes, Chimera Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Chimera Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0006954).
The registered office of Chimera Biotech is at Shed No. 199 2nd Floor Dsiidc Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.